Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthmaApproval based on global phase 3 program ...

Dupixent (dupilumab), a drug already used to treat atopic dermatitis and asthma, became the first biologic approved for chronic obstructive pulmonary disease (COPD) last fall. Most COPD treatments ...

Discusses Year-End Late-Stage Pipeline Review With Focus on Clinical and Regulatory Developments December 16, 2025 11:15 AM ...

With a fresh endorsement from the FDA, the last of five major drug approvals has fallen into place for GSK in 2025. | Tuesday ...

“Discarding unnecessary medication is really important. Exposure or accidental ingestion are concerns, especially if you have ...

(MENAFN- Market Press Release) December 13, 2025 7:27 am - The Dupixent market for moderate-to-severe asthma is valued at $3.25 billion in 2025 and is projected to grow at a 14% CAGR through 2032.

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Kymera Therapeutics reported on Monday that, for the second time this year, it has ...

Libtayo's approval for high-risk cutaneous squamous cell carcinoma offers a new immunotherapy option, targeting PD-1 ...

Fitness expert Denise Austin says weight-loss injections like Ozempic work, but warns muscle conditioning is key for lasting ...

These days, streaming services are a dime a dozen. Disney+ remains one of the most popular services, largely because of the amount of exclusive content. You'll not only have access to dozens of Disney ...

Tech billionaires Michael and Susan Dell announced Tuesday that they are pledging $6.25 billion to create some 25 million additional "Trump Accounts" for children across the country. These accounts ...

Anush Movsesian, whose clients include Hilary Duff and Kehlani, told The Post which five trends she’s staying away from — and her actual must-have for reliable anti-aging.